Literature DB >> 9163482

Detection of human papillomavirus type 16 early-gene transcription by reverse transcription-PCR is associated with abnormal cervical cytology.

C Biswas1, B Kell, C Mant, R J Jewers, J Cason, P Muir, K S Raju, J M Best.   

Abstract

Human papillomavirus type 16 (HPV-16) is associated with abnormal Papanicolou smears, indicative of cervical intraepithelial neoplasia. HPV-16 is the most common genital HPV and is found in up to 40% of young women with normal cervical cytology. In order to investigate whether transcriptionally active HPV-16 infection is associated with abnormal cervical smears, a reverse transcription-nested PCR assay with primers from the E5 open reading frame was developed to detect all HPV-16 early-region mRNA (E-mRNA) transcripts. It was used to study HPV-16-infected women with normal and abnormal cervical cytologies to obtain evidence of active infection. Among HPV-16 DNA-positive women, HPV-16 E-mRNA was detected in 15 of 37 (40.5%) women with abnormal cervical cytology but in only 4 of 35 (11.4%) women with normal cytology (P = 0.007). Thus, HPV-16 E-mRNA transcription is associated with abnormal cervical smears and may have value as a prognostic marker of progressive disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163482      PMCID: PMC229787          DOI: 10.1128/jcm.35.6.1560-1564.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  HPV in cervical smears.

Authors:  J Cuzick; G Terry; L Ho; T Hollingworth; M Anderson
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

Review 2.  Transcription of papillomavirus genomes.

Authors:  P G Fuchs; H Pfister
Journal:  Intervirology       Date:  1994       Impact factor: 1.763

3.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis.

Authors:  S Jeon; P F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes.

Authors:  S W Straight; P M Hinkle; R J Jewers; D J McCance
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Detection of the human papilloma virus type 16 mRNA-transcripts in cytological abnormal scrapings.

Authors:  C Falcinelli; E Claas; B Kleter; W G Quint
Journal:  J Med Virol       Date:  1992-06       Impact factor: 2.327

6.  Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens.

Authors:  P Muir; F Nicholson; M Jhetam; S Neogi; J E Banatvala
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

7.  Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected].

Authors:  J Cuzick; G Terry; L Ho; T Hollingworth; M Anderson
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

8.  Human papillomavirus type 16 and 18 gene expression in cervical neoplasias.

Authors:  M H Stoler; C R Rhodes; A Whitbeck; S M Wolinsky; L T Chow; T R Broker
Journal:  Hum Pathol       Date:  1992-02       Impact factor: 3.466

9.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.

Authors:  A T Lorincz; R Reid; A B Jenson; M D Greenberg; W Lancaster; R J Kurman
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

10.  Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.

Authors:  P J Bavin; J A Giles; A Deery; J Crow; P D Griffiths; V C Emery; P G Walker
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

View more
  5 in total

1.  High-risk human papillomavirus type 16 E7 oncogene associates with Cdc25A over-expression in oral squamous cell carcinoma.

Authors:  Ujjal Kumar Bhawal; Masaru Sugiyama; Yuji Nomura; Masahiko Sawajiri; Keiichi Tsukinoki; Masa-Aki Ikeda; Hiroki Kuniyasu
Journal:  Virchows Arch       Date:  2006-11-17       Impact factor: 4.064

2.  Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients.

Authors:  Dai-Wei Liu; Yuh-Cheng Yang; Ho-Fan Lin; Mei-Fang Lin; Ya-Wen Cheng; Chen-Chung Chu; Yeou-Ping Tsao; Show-Li Chen
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

3.  The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms.

Authors:  Kirsten Kabsch; Angel Alonso
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.

Authors:  Yi-Fang Chen; Chih-Wei Lin; Yeou-Ping Tsao; Show-Li Chen
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts.

Authors:  Rahul Nath; Christine A Mant; Barbara Kell; John Cason; Jon M Bible
Journal:  Cancer Cell Int       Date:  2006-08-09       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.